Hliðstæð aðferð við að framleiða nýjar (1-fenýl-1-heterósýklýl)metanól- og (1-fenýl-1-heterósýklýl)metýlamínafleiður
FIELD: organic chemistry, pharmacy. SUBSTANCE: invention describes new derivatives of oxazolyl- or thiazolylmethanol of the general formula (I) where X means O or S; R2 means H; R2 means H or lower alkyl; W means O or NH; R3 means H, lower alkyl or lower acyl; A means phenyl furyl, thienyl, naphthyl...
Saved in:
Main Authors | , , , |
---|---|
Format | Patent |
Language | Icelandic |
Published |
21.02.2000
|
Edition | 7 |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | FIELD: organic chemistry, pharmacy. SUBSTANCE: invention describes new derivatives of oxazolyl- or thiazolylmethanol of the general formula (I) where X means O or S; R2 means H; R2 means H or lower alkyl; W means O or NH; R3 means H, lower alkyl or lower acyl; A means phenyl furyl, thienyl, naphthyl, pyridyl or pyrrolyl possibly substituted with R6 where R6 means one or some groups taken among lower alkyl, halogen atom, lower alkoxy-group, CF3, OH, NO2 or NR4R5 where R4 and R5 mean independently H, lower alkyl or lower acyl, and pharmaceutically acceptable acid-additive salts under conditions that the following five compounds are not the subject of the present invention: 1-(4-methyl-5-thiazolyl)-1-phenylmethanol, 1-(2,4- -dimethyl-5-oxazolyl)-1-phenylmethanol, 1-(5-thiazolyl)-1- -phenylmethanol, 1-(4-oxazolyl)-1-phenylmethanol and 1-(2,4- -dimethyl-5-thiazolyl)-1-(2-chlorophenyl)-methanol. Compounds of the formula (I) elicite neuroprotective properties and can be used in medicine for treatment of patients with neurodegenerative disorders. Invention describes also a pharmaceutical composition based on the above indicated compounds. EFFECT: improved methods of synthesis, enhanced curative effectiveness of compounds. 12 cl, 58 ex |
---|---|
AbstractList | FIELD: organic chemistry, pharmacy. SUBSTANCE: invention describes new derivatives of oxazolyl- or thiazolylmethanol of the general formula (I) where X means O or S; R2 means H; R2 means H or lower alkyl; W means O or NH; R3 means H, lower alkyl or lower acyl; A means phenyl furyl, thienyl, naphthyl, pyridyl or pyrrolyl possibly substituted with R6 where R6 means one or some groups taken among lower alkyl, halogen atom, lower alkoxy-group, CF3, OH, NO2 or NR4R5 where R4 and R5 mean independently H, lower alkyl or lower acyl, and pharmaceutically acceptable acid-additive salts under conditions that the following five compounds are not the subject of the present invention: 1-(4-methyl-5-thiazolyl)-1-phenylmethanol, 1-(2,4- -dimethyl-5-oxazolyl)-1-phenylmethanol, 1-(5-thiazolyl)-1- -phenylmethanol, 1-(4-oxazolyl)-1-phenylmethanol and 1-(2,4- -dimethyl-5-thiazolyl)-1-(2-chlorophenyl)-methanol. Compounds of the formula (I) elicite neuroprotective properties and can be used in medicine for treatment of patients with neurodegenerative disorders. Invention describes also a pharmaceutical composition based on the above indicated compounds. EFFECT: improved methods of synthesis, enhanced curative effectiveness of compounds. 12 cl, 58 ex |
Author | ALFRED RICHARD GREEN DUNCAN ALASTAIR GRAY BERNARD ROBIN BOAR ALAN JOHN CROSS |
Author_xml | – fullname: ALFRED RICHARD GREEN – fullname: BERNARD ROBIN BOAR – fullname: ALAN JOHN CROSS – fullname: DUNCAN ALASTAIR GRAY |
BookMark | eNrjYmDJy89L5WTo9MjJPLyhuOTwssMbFBIPb0hLLQIyyjIhPIW0osTcnFQgL1Eh7_DerMQiBQ1D3bRUIDtH11A3I7UEqHxz8eG92TlAEc3c1JLEvMObc3QV8tMJKQRSibmH1-YlpoHNLy3iYWBNS8wpTuWF0twMsm6uIc4euqkF-fGpxQWJyal5qSXxnsGG5ibGTk7GhOQBFlpaFQ |
ContentType | Patent |
DBID | EVB |
DatabaseName | esp@cenet |
DatabaseTitleList | |
Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry Sciences |
Edition | 7 |
ExternalDocumentID | IS1743BB |
GroupedDBID | EVB |
ID | FETCH-epo_espacenet_IS1743BB3 |
IEDL.DBID | EVB |
IngestDate | Fri Jul 19 16:42:51 EDT 2024 |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | false |
Language | Icelandic |
LinkModel | DirectLink |
MergedId | FETCHMERGED-epo_espacenet_IS1743BB3 |
Notes | Application Number: IS19940004184 |
OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20000221&DB=EPODOC&CC=IS&NR=1743B |
ParticipantIDs | epo_espacenet_IS1743BB |
PublicationCentury | 2000 |
PublicationDate | 20000221 |
PublicationDateYYYYMMDD | 2000-02-21 |
PublicationDate_xml | – month: 02 year: 2000 text: 20000221 day: 21 |
PublicationDecade | 2000 |
PublicationYear | 2000 |
RelatedCompanies | AB ASTRA |
RelatedCompanies_xml | – name: AB ASTRA |
Score | 2.5160203 |
Snippet | FIELD: organic chemistry, pharmacy. SUBSTANCE: invention describes new derivatives of oxazolyl- or thiazolylmethanol of the general formula (I) where X means O... |
SourceID | epo |
SourceType | Open Access Repository |
SubjectTerms | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
Title | Hliðstæð aðferð við að framleiða nýjar (1-fenýl-1-heterósýklýl)metanól- og (1-fenýl-1-heterósýklýl)metýlamínafleiður |
URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20000221&DB=EPODOC&locale=&CC=IS&NR=1743B |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQSQQWccCy11w3ySjZUtfEwjBNN9HczFQ3OQVYvxoDs4h5Mmi8w9fPzCPUxCvCNIKJIRW2FwZ8Tmg5-HBEYI5KBub3EnB5XYAYxHIBr60s1k_KBArl27uF2LqowXrHoCrJUM3FydY1wN_F31nN2dnWM1jNL8gW1PB2YmZgBbWgQUfsu4Y5gTakFCDXJm6CDGwBQIPySoQYmDKLhRk4nWGXrgkzcPhC57qBTGi2KxZh6PTIyTy8objk8LLDGxQSD29ISy0CMsoyITyFtKLE3JxUIC9RIe_w3qzEIgUNQ920VCA7B9h1ywAteDm8ufjw3uwcoIhmLtBjeYc35-gq5KcTUgikEnMPr80DXfELNL-0SJRB1s01xNlDF-ineHjYxXsGg33uZCzGwJKXn5cqwaBgYJ5qap5kkpJibGRpkpSSapmUZGKckgZqPSUnAltTkgxi2M2QwiUhzcAF2aFupGtkKMPAUlJUmioLrKtLkuTAIQ0AEKSrWA |
link.rule.ids | 230,309,786,891,25594,76903 |
linkProvider | European Patent Office |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQSQQWccCy11w3ySjZUtfEwjBNN9HczFQ3OQVYvxoDs4h5Mmi8w9fPzCPUxCvCNIKJIRW2FwZ8Tmg5-HBEYI5KBub3EnB5XYAYxHIBr60s1k_KBArl27uF2LqowXrHoCrJUM3FydY1wN_F31nN2dnWM1jNL8gW1PB2YmZgNQf2BsG9pDAn0IaUAuTaxE2QgS0AaFBeiRADU2axMAOnM-zSNWEGDl_oXDeQCc12xSIMnR45mYc3FJccXnZ4g0Li4Q1pqUVARlkmhKeQVpSYm5MK5CUq5B3em5VYpKBhqJuWCmTnALtuGaAFL4c3Fx_em50DFNHMBXos7_DmHF2F_HRCCoFUYu7htXmgK36B5pcWiTLIurmGOHvoAv0UDw-7eM9gsM-djMUYWPLy81IlGBQMzFNNzZNMUlKMjSxNklJSLZOSTIxT0kCtp-REYGtKkkEMuxlSuCTkGTg9Qnx94n08_bylGbggu9WNdI0MZRhYSopKU2WB9XZJkhw41AE6hK5C |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Hli%C3%B0st%C3%A6%C3%B0+a%C3%B0fer%C3%B0+vi%C3%B0+a%C3%B0+framlei%C3%B0a+n%C3%BDjar+%281-fen%C3%BDl-1-heter%C3%B3s%C3%BDkl%C3%BDl%29metan%C3%B3l-+og+%281-fen%C3%BDl-1-heter%C3%B3s%C3%BDkl%C3%BDl%29met%C3%BDlam%C3%ADnaflei%C3%B0ur&rft.inventor=ALFRED+RICHARD+GREEN&rft.inventor=BERNARD+ROBIN+BOAR&rft.inventor=ALAN+JOHN+CROSS&rft.inventor=DUNCAN+ALASTAIR+GRAY&rft.date=2000-02-21&rft.externalDBID=B&rft.externalDocID=IS1743BB |